- Home
- ALVR vs HKIT Comparison
ALVR vs HKIT Comparison
Compare ALVR & HKIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALVR
- HKIT
- Stock Information
- Founded
- ALVR 2013
- HKIT 1996
- Country
- ALVR United States
- HKIT China
- Employees
- ALVR N/A
- HKIT N/A
- Industry
- ALVR Biotechnology: Biological Products (No Diagnostic Substances)
- HKIT Computer Software: Prepackaged Software
- Sector
- ALVR Health Care
- HKIT Technology
- Exchange
- ALVR Nasdaq
- HKIT Nasdaq
- Market Cap
- ALVR 52.2M
- HKIT 45.4M
- IPO Year
- ALVR 2020
- HKIT 2023
- Fundamental
- Price
- ALVR $0.40
- HKIT $1.31
- Analyst Decision
- ALVR Sell
- HKIT
- Analyst Count
- ALVR 5
- HKIT 0
- Target Price
- ALVR $1.00
- HKIT N/A
- AVG Volume (30 Days)
- ALVR 365.9K
- HKIT 26.7K
- Earning Date
- ALVR 11-12-2024
- HKIT 12-31-2024
- Dividend Yield
- ALVR N/A
- HKIT N/A
- EPS Growth
- ALVR N/A
- HKIT N/A
- EPS
- ALVR N/A
- HKIT 0.04
- Revenue
- ALVR N/A
- HKIT $3,449,206.00
- Revenue This Year
- ALVR N/A
- HKIT N/A
- Revenue Next Year
- ALVR N/A
- HKIT N/A
- P/E Ratio
- ALVR N/A
- HKIT $34.32
- Revenue Growth
- ALVR N/A
- HKIT N/A
- 52 Week Low
- ALVR $0.40
- HKIT $0.54
- 52 Week High
- ALVR $1.05
- HKIT $6.48
- Technical
- Relative Strength Index (RSI)
- ALVR 27.58
- HKIT 43.90
- Support Level
- ALVR $0.40
- HKIT $1.28
- Resistance Level
- ALVR $0.53
- HKIT $1.41
- Average True Range (ATR)
- ALVR 0.04
- HKIT 0.11
- MACD
- ALVR 0.00
- HKIT -0.00
- Stochastic Oscillator
- ALVR 1.35
- HKIT 15.28
About ALVR AlloVir Inc.
AlloVir Inc is a late clinical-stage cell therapy company. The company focuses on developing innovative allogeneic T-cell therapies to combat viral diseases. Their proprietary VST therapy platform enables the creation of off-the-shelf VSTs, addressing the urgent medical need for treating patients with limited viral disease treatment options. With a singular focus on research, development, and commercialization, the company's platform targets 11 devastating viruses, with posoleucel being the lead candidate addressing six viruses. Operating within one segment, the company is dedicated to preventing and treating severe viral-associated diseases through off-the-shelf VST therapies.
About HKIT Hitek Global Inc.
Hitek Global Inc is a provider of information technology consulting and solutions services. The company has two lines of businesses such as services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from hardware sales, software sales, IT services, and tax devices and services.